Provencio, Mariano <br/><br/>
Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years.  [electronic resource] 

 -  Leukemia & lymphoma  03 2019 
 - 856-859 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2018.1509322  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Consolidation Chemotherapy<br/>Follow-Up Studies<br/>Humans<br/>Induction Chemotherapy<br/>Kaplan-Meier Estimate<br/>Lymphoma, Follicular--drug therapy<br/>Molecular Targeted Therapy<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Retreatment<br/>Spain<br/>Treatment Outcome